Insulin and Proinsulin Dynamics Progressively Deteriorate From Within the Normal Range Toward Impaired Glucose Tolerance.

adiponectin glucose tolerance insulin secretion insulin sensitivity proinsulin

Journal

Journal of the Endocrine Society
ISSN: 2472-1972
Titre abrégé: J Endocr Soc
Pays: United States
ID NLM: 101697997

Informations de publication

Date de publication:
01 Jul 2020
Historique:
received: 31 03 2020
accepted: 29 05 2020
entrez: 4 7 2020
pubmed: 4 7 2020
medline: 4 7 2020
Statut: epublish

Résumé

Slight elevations in plasma glucose (PG) manifest in advance of diabetes onset, but abnormalities in immunoreactive insulin (IRI), proinsulin (Pro), and adiponectin dynamics during this stage remain poorly understood. The objective of this work is to investigate whether IRI and Pro dynamics become abnormal as glucose tolerance deteriorates from within the normal range toward impaired glucose tolerance (IGT), as well as the relationship between PG, and these dynamics and serum adiponectin levels. A cross-sectional study was designed. This study took place at Jichi Medical University in Japan. PG, IRI, and Pro levels were determined in 1311 young Japanese individuals (age < 40 years) with normal or IGT before and at 30, 60, and 120 minutes during a 75-g oral glucose tolerance test. Participants were assigned to 4 groups according to glucose tolerance, and then background factors, adiponectin levels, insulin sensitivity (SI), and insulin secretion (β) indexes were determined. PG levels as well as IRI and Pro levels 60 and 120 minutes after glucose-loading increased incrementally with deteriorating glucose tolerance. All measures of β and the SI measure index of insulin sensitivity (ISI)-Matsuda decreased incrementally. Serum adiponectin levels were not significantly different among the glucose tolerance groups, but were independently and negatively correlated with fasting glucose. Early β decreased and postloading Pro levels became excessive in a progressive manner as glucose tolerance deteriorated from within the normal range toward IGT.

Identifiants

pubmed: 32617449
doi: 10.1210/jendso/bvaa066
pii: bvaa066
pmc: PMC7316365
doi:

Types de publication

Journal Article

Langues

eng

Pagination

bvaa066

Informations de copyright

© Endocrine Society 2020.

Références

Diabetes Care. 2000 Mar;23(3):295-301
pubmed: 10868854
Diabetes Obes Metab. 2019 May;21(5):1191-1198
pubmed: 30663201
J Endocr Soc. 2018 Feb 19;2(3):279-289
pubmed: 29600294
Diabetes. 1999 Sep;48(9):1779-86
pubmed: 10480608
Diabetes Care. 2004 Jun;27(6):1433-8
pubmed: 15161800
Springerplus. 2014 May 20;3:252
pubmed: 24892003
Diabetes Care. 1999 Sep;22(9):1462-70
pubmed: 10480510
Diabetologia. 2018 Sep;61(9):1895-1901
pubmed: 29947922
N Engl J Med. 2010 Mar 4;362(9):800-11
pubmed: 20200384
Diabetes Care. 2004 Feb;27(2):547-52
pubmed: 14747242
Diabetes Care. 1999 Feb;22(2):262-70
pubmed: 10333943
Endocr Rev. 2016 Jun;37(3):278-316
pubmed: 27159875
Clin Endocrinol (Oxf). 2019 Nov;91(5):616-623
pubmed: 31408197
Sci Rep. 2018 Jan 10;8(1):406
pubmed: 29321603
Metabolism. 2003 Oct;52(10):1274-8
pubmed: 14564678
PLoS One. 2015 Feb 09;10(2):e0117044
pubmed: 25664814
Endocr J. 2006 Apr;53(2):247-54
pubmed: 16618984
Epidemiol Health. 2011;33:e2011007
pubmed: 21909476
Diabetes Care. 1996 Jan;19(1):8-11
pubmed: 8720525
PLoS One. 2015 Apr 08;10(4):e0124028
pubmed: 25853252
Diabetes Obes Metab. 2018 Jun;20(6):1419-1426
pubmed: 29400911
Diabetologia. 1988 Jun;31(6):355-60
pubmed: 3046976
J Diabetes Investig. 2010 Oct 19;1(5):212-28
pubmed: 24843435
J Clin Invest. 1967 Mar;46(3):323-35
pubmed: 6023769
BMJ Open Diabetes Res Care. 2016 Mar 17;4(1):e000194
pubmed: 27026810
BMJ Open Diabetes Res Care. 2019 Feb 7;7(1):e000596
pubmed: 30899529
J Intern Med. 2011 Jun;269(6):636-43
pubmed: 21198995
J Am Coll Cardiol. 2019 Oct 29;74(17):2162-2174
pubmed: 31648709
Diabetes Res Clin Pract. 2010 Nov;90(2):e33-6
pubmed: 20828849
Diabet Med. 1994 Apr;11(3):286-92
pubmed: 8033528
J Diabetes Investig. 2018 Sep;9(5):1106-1109
pubmed: 29451743
BMC Public Health. 2013 Oct 26;13:1014
pubmed: 24502249
J Clin Endocrinol Metab. 2019 Oct 1;104(10):4341-4346
pubmed: 31074785
Diabetologia. 1985 Jul;28(7):412-9
pubmed: 3899825
Clin Chem Lab Med. 2003 Sep;41(9):1234-8
pubmed: 14598875

Auteurs

Norimitsu Murai (N)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Naoko Saito (N)

Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University, Tochigi, Japan.

Eriko Kodama (E)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Tatsuya Iida (T)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Kentaro Mikura (K)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Hideyuki Imai (H)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Mariko Kaji (M)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Mai Hashizume (M)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Yasuyoshi Kigawa (Y)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Go Koizumi (G)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Rie Tadokoro (R)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Chiho Sugisawa (C)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Kei Endo (K)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Toru Iizaka (T)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Ryo Saiki (R)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Fumiko Otsuka (F)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.

Shun Ishibashi (S)

Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University, Tochigi, Japan.

Shoichiro Nagasaka (S)

Division of Diabetes, Metabolism and Endocrinology, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan.
Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical University, Tochigi, Japan.

Classifications MeSH